BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND TNFRSF17, BCMA, 608, ENSG00000048462, CD269, Q02223, BCM AND Prognosis
8 results:

  • 1. Prognostic stratification ability of the CPS+EG scoring system in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy.
    Roussot N; Constantin G; Desmoulins I; Bergeron A; Arnould L; Beltjens F; Mayeur D; Kaderbhai C; Hennequin A; Jankowski C; Padeano MM; Costaz H; Jacinto S; Michel E; Amet A; Coutant C; Costa B; Jouannaud C; Deblock M; Levy C; Ferrero JM; Kerbrat P; Brain E; Mouret-Reynier MA; Coudert B; Bertaut A; Ladoire S
    Eur J Cancer; 2024 May; 202():114037. PubMed ID: 38554542
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Novel models by machine learning to predict prognosis of breast cancer brain metastases.
    Li C; Liu M; Zhang Y; Wang Y; Li J; Sun S; Liu X; Wu H; Feng C; Yao P; Jia Y; Zhang Y; Wei X; Wu F; Du C; Zhao X; Zhang S; Qu J
    J Transl Med; 2023 Jun; 21(1):404. PubMed ID: 37344847
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Predicting the Incidence and prognosis of Bone Metastatic Breast cancer: A SEER-Based Observational Study.
    Shi D; Bai J; Chen Y; Wang X; Zhang Y; Liu H
    Biomed Res Int; 2020; 2020():1068202. PubMed ID: 33294433
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Applicability and limitations of a recently-proposed prognostic grading metric, initial brain metastasis velocity, for brain metastasis patients undergoing stereotactic radiosurgery.
    Yamamoto M; Aiyama H; Koiso T; Watanabe S; Kawabe T; Sato Y; Higuchi Y; Kasuya H; Barfod BE
    J Neurooncol; 2019 Jul; 143(3):613-621. PubMed ID: 31140039
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Subtype-specific signaling pathways and genomic aberrations associated with prognosis of glioblastoma.
    Park AK; Kim P; Ballester LY; Esquenazi Y; Zhao Z
    Neuro Oncol; 2019 Jan; 21(1):59-70. PubMed ID: 30053126
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. MiR-608 inhibits the migration and invasion of glioma stem cells by targeting macrophage migration inhibitory factor.
    Wang Z; Xue Y; Wang P; Zhu J; Ma J
    Oncol Rep; 2016 May; 35(5):2733-42. PubMed ID: 26935642
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients.
    Zhang G; Huang S; Zhang J; Wu Z; Lin S; Wang Y
    J Neurooncol; 2016 Apr; 127(2):355-62. PubMed ID: 26725096
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. APRIL is overexpressed in cancer: link with tumor progression.
    Moreaux J; Veyrune JL; De Vos J; Klein B
    BMC Cancer; 2009 Mar; 9():83. PubMed ID: 19291294
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.